Psst! Hey Doc...Got a Hot Stock Tip? - The questionable practice of physicians disclosing proprietary information to financial analysts for monetary compensation grows more pervasive every year - BioP

ADVERTISEMENT

Psst! Hey Doc...Got a Hot Stock Tip?
The questionable practice of physicians disclosing proprietary information to financial analysts for monetary compensation grows more pervasive every year


BioPharm International
Volume 18, Issue 12

What concerns me is the casual indifference on the part of doctors whose judgment patients must come to trust. It's a credibility and trust issue and doctors must always pass those types of tests. But what do we get? Quotes like the one Ben McGraw, an ex-Wall Street analyst at the California-based biotech firm Valentis, told The Seattle Times "Everybody does this.... It's now common practice."

Okay, so the practice of doctors talking to analysts is more pervasive these days. But that doesn't make it right. Any time money changes hands between doctors and slick Wall Street market mavens, any investor's antennae ought to go up (not to mention the patients who may one day use the drug in question).

Now it's time for this practice to fail its clinical trial.

Celebrity author and business/finance commentator for CNN and Fox News, Brian O'Connell has written for The Wall Street Journal and Newsweek,79 Radcliffe Drive,Doylestown,PA 18901,267.880.3144, fax 267.880.1939,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here